Mechanisms and role of microRNA deregulation in cancer onset and progression

Detalhes bibliográficos
Autor(a) principal: Palmero,Edenir Inês
Data de Publicação: 2011
Outros Autores: Campos,Silvana Gisele P de, Campos,Marcelo, Souza,Naiara C Nogueira de, Guerreiro,Ismael Dale C., Carvalho,Andre L., Marques,Marcia Maria C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Genetics and Molecular Biology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572011000300001
Resumo: MicroRNAs are key regulators of various fundamental biological processes and, although representing only a small portion of the genome, they regulate a much larger population of target genes. Mature microRNAs (miRNAs) are single-stranded RNA molecules of 20-23 nucleotide (nt) length that control gene expression in many cellular processes. These molecules typically reduce the stability of mRNAs, including those of genes that mediate processes in tumorigenesis, such as inflammation, cell cycle regulation, stress response, differentiation, apoptosis and invasion. MicroRNA targeting is mostly achieved through specific base-pairing interactions between the 5' end ('seed' region) of the miRNA and sites within coding and untranslated regions (UTRs) of mRNAs; target sites in the 3' UTR diminish mRNA stability. Since miRNAs frequently target hundreds of mRNAs, miRNA regulatory pathways are complex. Calin and Croce were the first to demonstrate a connection between microRNAs and increased risk of developing cancer, and meanwhile the role of microRNAs in carcinogenesis has definitively been evidenced. It needs to be considered that the complex mechanism of gene regulation by microRNAs is profoundly influenced by variation in gene sequence (polymorphisms) of the target sites. Thus, individual variability could cause patients to present differential risks regarding several diseases. Aiming to provide a critical overview of miRNA dysregulation in cancer, this article reviews the growing number of studies that have shown the importance of these small molecules and how these microRNAs can affect or be affected by genetic and epigenetic mechanisms.
id SBG-1_3ca152ffb62e93824eee6b90fc794ec3
oai_identifier_str oai:scielo:S1415-47572011000300001
network_acronym_str SBG-1
network_name_str Genetics and Molecular Biology
repository_id_str
spelling Mechanisms and role of microRNA deregulation in cancer onset and progressionmicroRNAcancergenetic alterationepigenetic alterationtherapeutic applicationMicroRNAs are key regulators of various fundamental biological processes and, although representing only a small portion of the genome, they regulate a much larger population of target genes. Mature microRNAs (miRNAs) are single-stranded RNA molecules of 20-23 nucleotide (nt) length that control gene expression in many cellular processes. These molecules typically reduce the stability of mRNAs, including those of genes that mediate processes in tumorigenesis, such as inflammation, cell cycle regulation, stress response, differentiation, apoptosis and invasion. MicroRNA targeting is mostly achieved through specific base-pairing interactions between the 5' end ('seed' region) of the miRNA and sites within coding and untranslated regions (UTRs) of mRNAs; target sites in the 3' UTR diminish mRNA stability. Since miRNAs frequently target hundreds of mRNAs, miRNA regulatory pathways are complex. Calin and Croce were the first to demonstrate a connection between microRNAs and increased risk of developing cancer, and meanwhile the role of microRNAs in carcinogenesis has definitively been evidenced. It needs to be considered that the complex mechanism of gene regulation by microRNAs is profoundly influenced by variation in gene sequence (polymorphisms) of the target sites. Thus, individual variability could cause patients to present differential risks regarding several diseases. Aiming to provide a critical overview of miRNA dysregulation in cancer, this article reviews the growing number of studies that have shown the importance of these small molecules and how these microRNAs can affect or be affected by genetic and epigenetic mechanisms.Sociedade Brasileira de Genética2011-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572011000300001Genetics and Molecular Biology v.34 n.3 2011reponame:Genetics and Molecular Biologyinstname:Sociedade Brasileira de Genética (SBG)instacron:SBG10.1590/S1415-47572011000300001info:eu-repo/semantics/openAccessPalmero,Edenir InêsCampos,Silvana Gisele P deCampos,MarceloSouza,Naiara C Nogueira deGuerreiro,Ismael Dale C.Carvalho,Andre L.Marques,Marcia Maria C.eng2011-08-05T00:00:00Zoai:scielo:S1415-47572011000300001Revistahttp://www.gmb.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||editor@gmb.org.br1678-46851415-4757opendoar:2011-08-05T00:00Genetics and Molecular Biology - Sociedade Brasileira de Genética (SBG)false
dc.title.none.fl_str_mv Mechanisms and role of microRNA deregulation in cancer onset and progression
title Mechanisms and role of microRNA deregulation in cancer onset and progression
spellingShingle Mechanisms and role of microRNA deregulation in cancer onset and progression
Palmero,Edenir Inês
microRNA
cancer
genetic alteration
epigenetic alteration
therapeutic application
title_short Mechanisms and role of microRNA deregulation in cancer onset and progression
title_full Mechanisms and role of microRNA deregulation in cancer onset and progression
title_fullStr Mechanisms and role of microRNA deregulation in cancer onset and progression
title_full_unstemmed Mechanisms and role of microRNA deregulation in cancer onset and progression
title_sort Mechanisms and role of microRNA deregulation in cancer onset and progression
author Palmero,Edenir Inês
author_facet Palmero,Edenir Inês
Campos,Silvana Gisele P de
Campos,Marcelo
Souza,Naiara C Nogueira de
Guerreiro,Ismael Dale C.
Carvalho,Andre L.
Marques,Marcia Maria C.
author_role author
author2 Campos,Silvana Gisele P de
Campos,Marcelo
Souza,Naiara C Nogueira de
Guerreiro,Ismael Dale C.
Carvalho,Andre L.
Marques,Marcia Maria C.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Palmero,Edenir Inês
Campos,Silvana Gisele P de
Campos,Marcelo
Souza,Naiara C Nogueira de
Guerreiro,Ismael Dale C.
Carvalho,Andre L.
Marques,Marcia Maria C.
dc.subject.por.fl_str_mv microRNA
cancer
genetic alteration
epigenetic alteration
therapeutic application
topic microRNA
cancer
genetic alteration
epigenetic alteration
therapeutic application
description MicroRNAs are key regulators of various fundamental biological processes and, although representing only a small portion of the genome, they regulate a much larger population of target genes. Mature microRNAs (miRNAs) are single-stranded RNA molecules of 20-23 nucleotide (nt) length that control gene expression in many cellular processes. These molecules typically reduce the stability of mRNAs, including those of genes that mediate processes in tumorigenesis, such as inflammation, cell cycle regulation, stress response, differentiation, apoptosis and invasion. MicroRNA targeting is mostly achieved through specific base-pairing interactions between the 5' end ('seed' region) of the miRNA and sites within coding and untranslated regions (UTRs) of mRNAs; target sites in the 3' UTR diminish mRNA stability. Since miRNAs frequently target hundreds of mRNAs, miRNA regulatory pathways are complex. Calin and Croce were the first to demonstrate a connection between microRNAs and increased risk of developing cancer, and meanwhile the role of microRNAs in carcinogenesis has definitively been evidenced. It needs to be considered that the complex mechanism of gene regulation by microRNAs is profoundly influenced by variation in gene sequence (polymorphisms) of the target sites. Thus, individual variability could cause patients to present differential risks regarding several diseases. Aiming to provide a critical overview of miRNA dysregulation in cancer, this article reviews the growing number of studies that have shown the importance of these small molecules and how these microRNAs can affect or be affected by genetic and epigenetic mechanisms.
publishDate 2011
dc.date.none.fl_str_mv 2011-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572011000300001
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572011000300001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1415-47572011000300001
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Genética
publisher.none.fl_str_mv Sociedade Brasileira de Genética
dc.source.none.fl_str_mv Genetics and Molecular Biology v.34 n.3 2011
reponame:Genetics and Molecular Biology
instname:Sociedade Brasileira de Genética (SBG)
instacron:SBG
instname_str Sociedade Brasileira de Genética (SBG)
instacron_str SBG
institution SBG
reponame_str Genetics and Molecular Biology
collection Genetics and Molecular Biology
repository.name.fl_str_mv Genetics and Molecular Biology - Sociedade Brasileira de Genética (SBG)
repository.mail.fl_str_mv ||editor@gmb.org.br
_version_ 1752122383750135808